Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-24-Speech-3-972"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20101124.15.3-972"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Directive 2001/83/EC establishes a Community code relating to medicinal products for human use. It lays down rules on the information to be annexed to medicinal products concerning their characteristics and use. Nonetheless, it does not provide a harmonised framework on the contents and the quality of non-promotional information for patients. Furthermore, experience has shown that different interpretations of the texts could lead to situations where the general public is exposed to disguised advertising, especially on the Internet. The Commission has proposed a directive which amends the current legislation in order to improve the way in which information relating to prescription-only medicines is disseminated to the general public. It aims to establish a legal framework governing the dissemination of specific information on medicinal products from marketing authorisation holders to the general public. The European Parliament has drafted a legislative resolution which is more ambitious than the Commission’s proposal. I voted for this text as it improves the information made available to patients and makes it a little safer still."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples